T. Sokolova

Changes in the concentration of EGFR-mutated plasma DNA in the first hours of targeted therapy allow the prediction of tumor response in patients with EGFR-driven lung cancer

E. Imyanitov, F. Moiseyenko, E. Kuligina, 2022, International Journal of Clinical Oncology.

First-Line Cetuximab Monotherapy in KRAS/NRAS/BRAF Mutation-Negative Colorectal Cancer Patients

A. Sokolenko, E. Imyanitov, E. Preobrazhenskaya, 2018, Clinical Drug Investigation.

Clinical and morphological features of breast tumors with PIK3CA mutations in Russian patients: Observational study

A. M. Degtyarev, R. Zukov, A. Vasilevskaya, 2022, Journal of Modern Oncology.

Content of circulating tumor DNA depends on the tumor type and the dynamics of tumor size, but is not influenced significantly by physical exercise, time of the day or recent meal.

E. Imyanitov, M. Anisimova, E. Kuligina, 2021, Cancer genetics.

COURSE OF HIV INFECTION AND MECHANISMS OF PREGNANCY FAILURE DEVELOPMENT IN WOMEN LIVING IN THE SUBARCTIC REGION

L. Kovalenko, T. Sokolova, A. E. Kasparova, 2020 .